Silverberg Bernstein Capital Management LLC Pharming Group N.V. Transaction History
Silverberg Bernstein Capital Management LLC
- $173 Billion
- Q4 2025
A detailed history of Silverberg Bernstein Capital Management LLC transactions in Pharming Group N.V. stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 50,547 shares of PHAR stock, worth $849,695. This represents 0.52% of its overall portfolio holdings.
Number of Shares
50,547
Previous 52,147
3.07%
Holding current value
$849,695
Previous $756 Million
18.12%
% of portfolio
0.52%
Previous 0.46%
Shares
6 transactions
Others Institutions Holding PHAR
# of Institutions
9Shares Held
79KCall Options Held
0Put Options Held
0-
Cowen Prime Advisors LLC22.5KShares$377,5520.09% of portfolio
-
Morgan Stanley New York, NY4.36KShares$73,2070.0% of portfolio
-
Ever Source Wealth Advisors, LLC1.38KShares$23,1470.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA253Shares$4,2520.0% of portfolio
-
Global Retirement Partners, LLC23Shares$3860.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $1.1B
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...